Fig. 1 · Structure
Documents & Downloads
Doxefazepam
Benzodiazepine Derivative
Doxefazepam is a benzodiazepine derivative that primarily targets the central nervous system. It exhibits anxiolytic, anticonvulsant, and skeletal muscle relaxant properties, making it useful for research on anxiety disorders, seizure activity, and muscular spasticity. This compound provides a valuable tool for investigating the pharmacological effects of benzodiazepines in various preclinical studies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 40762-15-0 |
| Applications | Benzodiazepine Derivative |
| Formula | C17H14ClFN2O3 |
| Molecular Weight | 348.76 |
| Synonyms | SAS-643 |
| SMILES | O=C1N(CCO)C2=CC=C(Cl)C=C2C(C3=CC=CC=C3F)=NC1O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.